Abstract
The prognostic of SLE has progressively improved, especially during the past decade (1), and considerable advance has been made in the prognosis of lupus nephritis as well.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Schwartz RS, Immunologic and genetic aspects of systemic lupus erythematosus, kidney Int. 19: 474 (1981).
Morel Maroger L, Mery JPH, Droz D, Godin M, Verroust P, Kourilsky O, Richet G, The course of lupus nephritis: contribution of serial renal biopsies. Adv. Nephrol. 6: 79 (1976).
Cameron JS, Turner DR, Ogg CS, Williams DG, Lessof MH, Chantler C, Leibowitz S, Systemic lupus with nephritis: A long-term study. Quart.J.Med. 48: 1 (1979).
Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois EL, Systemic lupus erythematosus-survival patterns JAMA 245: 934 (1981).
Appel GB, Cohen DJ, Pirani CL, Meitzer JI, Estes D, Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization, Am.J.Med. 83: 877 (1987).
Leaker B, Fairley KF, Dowling J, Kincaid-Smith P, Lupus nephritis: clinical and pathological correlation. Quart. J. Med 62: 163 (1987).
Muehrcke RC, Kark RM, Pirani CL, Pollak VE, Lupus nephritis: a clinical and pathologic study based on renal biopsies, Medicine 36: 1 (1957).
Baldwin DS, Lowenstein J, Rothifield NF, Gallo G, McCluskey RT, The clinical course of the pro I iferative and membranous forms of lupus nephritis, Ann. Intern.Med. 73: 929 (1970).
Decker JL, Klippel JH, Plotz PK, Steinberg AD, Cyclophosphamide and azathioprine in lupus glomeru loneph- ritis: A controlled trial: results at 28 months, Ann.Intern._Med. 83: 606 (1975).
Ponticelli C, Zucchelli P, Moroni G, Cagnoli L, Banfi G, Pasquali S, Long-term prognosis of diffuse lupus nephritis, Clin.Nephrol. 22: 263 (1987).
Steinberg AD, The treatment of lupus nephritis. Kidney Int. 30: 769 (1986).
Zweiman B, Kornblum J, Cornog J, Hildret EA, The prognosis of lupus nephritis. Role of clinical pathological correlations, Ann.Intern.Med. 69:441 (1968).
Hecht B, Siegel N, Adler M, Kashgarian M, Ayslett JF, Prognostic indices in lupus nephritis, Medicine 55: 163 (1976).
Ginzier EH, Diamond HS, Weiner M, Schlesinger M, Fries JF, Wasner C, Medsger TA, Ziegler G, Klippel JH, Hadler NM, Albert DA, Hess EV, Spencer-Green G, Grayzel A, Worth D, Hahn BH, Barnett EV, A multicenter study of outcome in systemic lupus erythematosus I. Entry Variables as predictors of prognosis, Arth. Rheum. 25: 601 (1982).
Austin HA, Muenz LR, Joyce KM, Antonovych TA, Kullick ME Klippel JN, Decker JL, Balow JE, Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am.J.Med. 75: 332 (1983)
Banfi G, Mazzucco G, Barbiano di Belgiojoso G, Bestetti Bosisio M, Stratta P, Confalonieri R, Ferrario F, Imbasciati E, Monga G, Morphological parameters in lupus nephritis: their relevance for classification and relationship with clinical and histological findings and outcome, Quart.J.Med. 55: 153 (1985).
Tan EM, Cohen AS, Fries IF, Masi AJ, McShane DJ, Roth- field NF, Schaller JG, Talal N, Winchester JR: The 1982 revised criteria for the classification of systemic lupus erythematosus, Arthiritis Rheum. 25: 1271 (1982)
Appel GB, Silva FG, Pirani CL, Meitzer JI, Estes D: Renal involvement in systemic lupus erythematosus. A study of 56 patients emphasizing histologic classification, Medicine 57: 371 (1978).
Lachenbruch PA, Clarke WR: Discriminant analysis and its application in epidemiology. Meth. Infgrm.Med. 19: 220 (1980).
Decker JL, Steinberg AD, Reinertsen JL, Plotg PH, Balow JE, Klippel JH, Systemic lupus erythematosus: evolving concepts. Ann.Intern. Med. 91: 587 (1979).
Fish AJ, Blau EB, Westburg NG, Burke BA, Vernier RL, Michael AF, SLE within the first two decades of life, Arn.J.Med. 62: 99 (1977).
Magil AB, Ballon HS, Chan V, Lirenman DS, Rac A., Sutton RAL, Diffuse prolipherative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors. Medicine 63: 210 (1984).
Balow JE, Therapeutic trials in lupus nephritis. Problems related to renal histology, monitoring of therapy and measures of outcome. Nephron 27: 171 (1981)
McCluskey RT, The value of the renal biopsy in lupus nephritis. Arthr.Rheum.,25: 867 (1982).
Wallace DJ, Podell TE, Weiner JM, Cox MB, Klinenberg JR, Forouresh S, Dubois EL, Lupus nephritis. Experience with 230 patients in a private prat ice from 1950 to 1980.Am.J.Med. 72:209 (1982)
Fries JF, Porta J, Liang MH, Marginal benefit of renal biopsy in systemic lupus erythematosus. Arch. Intern.Med. 138: 1386 (1978).
Whiting-O’Keafe Q, Heuke JE, Shearn MA, Hopper J, Biava CG, Epstein WV, The information cntent from renal biopsy in systemic lupus erythematosus, Ann. Intern. Med. 96:718 (1982).
Austin HA, Muenz LR, Joyce KM, Antonovych TT, Balow, Diffuse proliperative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney. 25: 689 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Coratelli, P., Rizzi, R., Pannarale, G., Ramunni, A., Giannattasio, M., Passavanti, G. (1989). Prognostic Determinants in Lupus Nephritis. In: Amerio, A., Coratelli, P., Campese, V.M., Massry, S.G. (eds) Drugs, Systemic Diseases, and the Kidney. Advances in Experimental Medicine and Biology, vol 252. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8953-8_2
Download citation
DOI: https://doi.org/10.1007/978-1-4684-8953-8_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-8955-2
Online ISBN: 978-1-4684-8953-8
eBook Packages: Springer Book Archive